Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Research use only, not for human use
Based on Lilly's pricing for Zepbound (tirzepatide) and industry analyst estimates, retatrutide is expected to cost approximately $349-499/month through manufacturer direct-to-consumer programs like LillyDirect, with list prices likely exceeding ,000/month
Gastrin is a hormone that spikes colonic motor activity
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
10.1007/s00404-012-2439-7 47
Availability varies by country
US$ 21.07
US$ 23.34
US$ 27.58
US$ 24.19
US$ 22.23
